Related topics

Agios Pharmaceuticals: 4Q Earnings Snapshot

February 25, 2021 GMT

CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $97.7 million in its fourth quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.41.

The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of $1.41 per share.

The biopharmaceutical company posted revenue of $44 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $36.3 million.

For the year, the company reported that its loss narrowed to $327.4 million, or $4.74 per share. Revenue was reported as $203.2 million.

Agios Pharmaceuticals shares have increased 22% since the beginning of the year. The stock has climbed 6.5% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO